KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) EBT: 2009-2024

Historic EBT for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $4.5 billion.

  • Cme Group's EBT rose 0.01% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year increase of 8.94%. This contributed to the annual value of $4.5 billion for FY2024, which is 9.34% up from last year.
  • As of FY2024, Cme Group's EBT stood at $4.5 billion, which was up 9.34% from $4.2 billion recorded in FY2023.
  • Over the past 5 years, Cme Group's EBT peaked at $4.5 billion during FY2024, and registered a low of $2.7 billion during FY2020.
  • Moreover, its 3-year median value for EBT was $4.2 billion (2023), whereas its average is $4.1 billion.
  • Data for Cme Group's EBT shows a peak YoY grew of 23.93% (in 2021) over the last 5 years.
  • Over the past 5 years, Cme Group's EBT (Yearly) stood at $2.7 billion in 2020, then rose by 23.93% to $3.4 billion in 2021, then grew by 3.46% to $3.5 billion in 2022, then climbed by 19.00% to $4.2 billion in 2023, then rose by 9.34% to $4.5 billion in 2024.